baber/WOPTO huggingface dataset:
Patent NZ-268058-A (NZ)
Title: Paper making process using a non ionic polymeric retention aid in a cellulosic suspension
Inventor: CAULEY THOMAS ADRIAN
IPC: D21H23/14
Filed: 1994-07-06
Abstract: Paper is made by adding nonionic or anionic polymeric retention aid to a suspension that contains a high electrolyte content, shearing the flocculated suspension, aggregating the sheared suspension by adding anionic particulate material (especially bentonite), and draining the suspension.
Patent NZ-294880-A (NZ)
Title: Taxoid derivatives; preparation and medicaments
Inventor: BOUCHARD HERVE
IPC: A61K31/337
Filed: 1995-10-23
Abstract: PCT No. PCT/FR95/01393 Sec. 371 Date Apr. 24, 1997 Sec. 102(e) Date Apr. 24, 1997 PCT Filed Oct. 23, 1995 PCT Pub. No. WO96/13494 PCT Pub. Date May 9, 1996This invention relates to compounds of the formula (I), preparation thereof, and pharmaceutical compositions containing them:    <IMAGE>  (I)  wherein: Ra is hydrogen, hydroxyl, alkoxy, acyloxy, or an alkoxyacetoxy radical; Rb is hydrogen; or Ra and Rb, together with the carbon atom to which they are attached, form a ketone function; Z represents a hydrogen atom or a radical of formula (II): nally substituted benzoyl, thenoyl, furoyl, or R2-O-CO- radical where R2 is an alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, bicycloalkyl, or an optionally substituted phenyl or heterocyclic radical; R3 is an aromatic heterocyclic, alkyl, alkenyl, alkynyl, cycloalkyl, or a phenyl or naphthyl radical; R4 is alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, bicycloalkyl, aryl, or heterocyclic radical; and R5 is an optionally substituted cycloalkenyl, alkyl, alkenyl, alkynyl, or cycloalkyl radical. The compounds of formula (I), where Z is a formula (II) radical, have remarkable antitumoral and antineoplastic properties
Patent NZ-327098-A (NZ)
Title: Wraparound carrier for tub-type containers: includes divider flaps which engage underside of containers
Inventor: NAUMANN FREDERICK
IPC: B65D71/28
Filed: 1997-02-25
Abstract: A wrap-around tub carrier (10) with a top centre divider tab (34). The tab is comprised of spaced segments of a flap (84) which is foldably connected to the top panel (12). Both the divider tab and a locking tab (36) located between the divider tab segments are connected by a fold line (88) to another locking tab (38). Both locking tabs extend up to engage the flange (F) of adjacent tubs on opposite sides of the divider tab. A triangular keel extends up between the rows of tubs and a keel support tab extends up within the keel to provide additional support.
Patent NZ-333794-A (NZ)
Title: Packaging film with transverse cuts
Inventor: ALBRECHT BERND
IPC: B65B61/18
Filed: 1997-06-17
Abstract: A package is disclosed which consists substantially of plastic film and has means for opening the package without the aid of a tool.   A method for forming the package is also disclosed.  The plastic film (10) is supplied from the roll to a cutting station in which cuts (11) are provided in a cycle adapted to the size of the final package, the width of said cuts being smaller than the width of the plastic film, and said cuts pass completely through the thickness of said plastic film.
Patent NZ-334591-A (NZ)
Title: Process for the synthesis of benzothiophenes using cation exchange resins
Inventor: VICENZI JEFFREY T
IPC: C07D333/56
Filed: 1997-09-19
Abstract: The compound of formula Ib is prepared by cyclizing the dialkoxy compound of formula II in the presence of a cation exchange resin, such as a polystyrene-based sulfonic acid resin.   The cyclization process is carried out at a temperature of 70 to 90 C. The compound of formula Ib can be rearranged to form a compound of formula I, by contacting the reaction mixture with methanesulfonic acid in toluene, and heptane.  The compound of formula I can be acylated with a compound of formula III(a), and this product can be salified to form a compound of formula III(b). In formula I, I(b), II and III(b), the R groups are the same or different and represent C1-6 alkyl.  In formula III(a) and III(b), R1 and R2 are independently C1-C6 alkyl, or they combine with the nitrogen to which they are attached to  form piperidinyl, pyrrolidinyl, methylpyrrolidinyl, dimethylpyrrolidinyl or hexamethyleneimino.
Patent NZ-334838-A (NZ)
Title: Control of carbon dioxide and nitrogen levels during dispensing of beer
Inventor: PAGE JOHN KENNETH RURIK
IPC: B67D1/00
Filed: 1999-03-25
Abstract: A beverage dispensing apparatus maintains a predetermined quantity of dissolved gas in the beverage.  The beverage is contained in a pressurised reservoir 62 and is passed through a contactor module 98 containing hollow fibre membranes.  The gas space in contactor 98 is connected to a three-way valve 114, which in turn is connected to three-way valves 115 and 124.  Valve 116 has ports 7, 9 which are connected to a high pressure source of  a first gas 122, and a reduced pressure of the same gas via reducing valve 116.  Valve 124 has ports 4, 6, which are connected to atmosphere and to a source 132 of a second gas.  When beverage is not being dispensed, ports 2 and 3 of valve 114 are open so that the first gas is fed to the contactor.  The choice of whether the first gas is supplied directly from source 122, or via pressure reducing valve 116 is made by control unit 136, according to the frequency of draws of beverage from tap 106.  When beverage is drawn off, and beverage flows through contactor 98, the gas space of the contactor is connected to atmosphere via ports 1, 5 and 6, so that excess pressure of the first gas can bleed off.  Then port 4 of valve 124 is opened to allow the second gas to flow into the contactor.  When the flow of beverage stops, the contactor is vented to atmosphere, and connected to valve 114 to allow the first gas into the contactor.  The beverage may be beer, and the first gas may be nitrogen, with the second gas being carbon dioxide.
Patent NZ-335626-A (NZ)
Title: Molten metal pump and method of using
Inventor: AREAUX LARRY D
IPC: F27D3/14
Filed: 1997-11-05
Abstract: An inert gas bubble-actuated molten metal pump (PU) is located between one section of a metal-melting furnace (10) and a second section to pump molten metal from the one section.  The molten metal is at a higher temperature, in the second section.  The molten metal (26) is at a lower temperature, and its effluent is directed into contact with metal chips (80) being charged into the second section, thereby assisting in the more rapid melting of the chips into the molten metal (26) mass in the second section.  The inert gas (IG) employed to actuate the molten metal pump (PU), is captured beneath a heat-resistant and flame-resistant cover (30) located above the exit port of the pump (PU) and over a substantial portion of the molten (26) mass in the second section, thereby providing a non-oxidizing atmosphere at the surface of the molten metal (26) mass or pool beneath cover (30).  In this manner the inert gas (IG) is employed not only to actuate the inert gas bubble-actuated molten metal pump (PU), but also to assist in the rapid melting of metal chips (80) being charged, as well as to provide a non-oxidizing atmosphere at the surface of the molten metal (26).
Patent NZ-335674-A (NZ)
Title: Glass fibres for reinforcing organic and/or inorganic materials
Inventor: GALLO MARCELO HERNAN
IPC: C03C13/00
Filed: 1998-09-10
Abstract: Reinforcing glass yarns comprising: SiO2-58 to 62%, Al2O3-10 to 16%, CaO-> 18%,  MgO-> 1.5%,  CaO + MgO-< 28%, Na2O + K2O + Li2O-< 2%, TiO2-< 1.5%, Fe2O3-< 0.5%, B2O3-< 2%, F2-<2%, F2 or B2O3-> 0.5% in percentages by weight. These yarns have a composition providing a compromise between its cost and its fiberizability.
Patent NZ-502546-A (NZ)
Title: Treatment of acute lung injury and fibrosis with antibodies to alpha-v-beta-6
Inventor: HUANG XIAOZHU
IPC: A61K48/00
Filed: 1998-08-07
Abstract: Antibodies specific for b6 integrin may be used for treating or preventing acute lung injury and pulmonary fibrosis.
Patent NZ-504743-A (NZ)
Title: Roof ventilation with fan having horizontal axis contained in cowling below roof ridge, typically for conservatory
Inventor: RICHARDSON CHRISTOPHER
IPC: E04D3/40
Filed: 1998-09-07
Abstract: A conservatory roof ventilation system comprising a ridge beam (10), the ridge beam having a base side walls (16) and side flanges (14) for supporting glazing bars, the base (12) having at least one ventilation aperture therein, a cowl (22) attachable to the ridge beam underside at a selectable position along the length of the ridge beam.  An electrically operated rotor (24) within the cowl and arranged to rotate on a axis generally parallel with the ridge beam, the cowl communicating with at least one ventilation aperture in the ridge beam and an apertured cover (36) mounted on the ridge beam underside for concealing the rotor from below.
Patent NZ-505446-A (NZ)
Title: Circulator with permanent magnet(s) and ferrite block(s) having magnetic characteristics to provide thermostable operation over predetermined temperature range
Inventor: BUTLAND ROGER JOHN
IPC: H01P1/383
Filed: 1997-04-02
Abstract: Ferrite block(s) 40, 41 are contained within overlying crossing strips (not shown) with one face of the block(s) located adjacent to the strips and the other face exposed to allow direct contact with a circulator housing body (not shown).
Patent NZ-506150-A (NZ)
Title: A ticket holder
Inventor: POWELL JOHN ROBERT
IPC: A45C11/18
Filed: 2000-08-07
Abstract: A ticket holder (1) including:  (a) a first face (3), against which a ticket may be placed,  (b) a second face (4), having retention means (5) for securing the ticket against the first (3) and/or the second face (4) and/or within the holder (1),  (c) the first face (3) being provided with indication means (7) to allow for a day and/or month of the ticket purchase and/or intended day of use to be indicated on the holder (1) and/or the first face (3).
Patent NZ-506348-A (NZ)
Title: Riser pipe construction and module therefor
Inventor: VAN DER POEL HANS
IPC: E21B17/01
Filed: 1999-02-16
Abstract: A riser pipe construction (5) for a drilling connection from  a  drilling  vessel  (1) to  a  valve  (6)  previously provided  on a sea floor (8) comprises a riser pipe  through which drilling means can be passed by means of which an  oil well  can  be  drilled,  as  well  as  pressure  pipes  (11) extending  along the riser pipe to operate  the  valve,  and floating  elements disposed around the riser  pipe  and  the pressure  pipes  to limit the load on the  drilling  vessel. The  riser  pipe and the pressure pipes are  built  up  from modules  capable  of  being coupled together.  The  floating elements are formed by steel tubular chambers closed  so  as to  be  gastight, disposed around the relevant  modules  and firmly connected thereto. The disclosure also relates  to  a riser pipe module.
Patent NZ-507303-A (NZ)
Title: Quinolin-4-yl derivatives II and their use in treating neurodegenerative disease
Inventor: HEITZ NEIDHART MARIE-PAULE
IPC: A61P29/00
Filed: 2000-10-03
Abstract: Compounds of the general formula I are described wherein R1 is hydrogen. lower alkyl, lower alkoxy. hydroxy, amino, nitro, cyano, lower alkyl-amino, di-lower alkyl-amino or halogen; R2 is hydrogen. lower alkyl, amino, pyrrolidin-3-ol, pyrrolidin-2-yl-methanol or -NHCH2CHROH; R3 is hydrogen or halogen; N is 1 or 2 The compounds of formula I are NMDA (N-methyl-D-aspartate)-receptor subtype selective blockers, which have the key function in modulating neuronal activity and plasticity.  This property makes them key players in mediating processes underlying development of the CNS as well as learning and memory formation.  The compounds and be used in medicaments to treat conditions such as Alzheimer's disease, Parkinson's disease, Huntington's disease, ALS (amyotrophic lateral sclerosis) and neurodegeneration associated with bacterial or viral infections, and chronic and acute pain.
Patent NZ-507886-A (NZ)
Title: Multivalent T cell receptor complexes
Inventor: JAKOBSEN BENT KARSTEN
IPC: A61K47/48
Filed: 1999-05-19
Abstract: Synthetic multivalent T cell receptor (TCR) complex for binding to a MHC-peptide complex.  The multivalent complex comprises a plurality of soluble TCR, at least one of which is specific for the MHC-peptide complex, associated with one another via a reaction with a linker molecule.
Patent NZ-508182-A (NZ)
Title: A method involving an antibacterial, which is an inhibitor of a bacterial RNA polymerase sigma subunit, useful in the treatment of bacterial infections
Inventor: BALGANESH TANJORE
IPC: C12Q1/48
Filed: 1999-06-07
Abstract: A method of identifying a ligand of a bacterial sigma70 subunit which comprises contacting the sigma70 subunit or a portion thereof comprising the anti-sigma binding region, with a test compound and a fusion protein (which can comprise a glutathione-S-transferase) of an anti-sigma70 factor of bacteriophage T4, and determining whether the test compound binds competitively with the anti-sigma70 factor to the sigma70 subunit or portion thereof.
Patent NZ-517070-A (NZ)
Title: Infection with chimaeric adenoviruses of cells negative for the adenovirus serotype 5 Coxsacki adenovirus receptor (CAR)
Inventor: HAVENGA MENZO
IPC: A61K48/00
Filed: 2000-07-07
Abstract: A chimaeric adenovirus based on at least two different adenoviruses, whereby a cell-recognizing element of said chemaeric adenovirus is based on adenoviral material from a subgroup D and/or F adenovirus, which material confers the capability of infecting CAR negative cells, said chimaeric adenovirus further comprising an element from adenovirus 35 or a functional equivalent thereof, responsible for at least partially avoiding an immune response against adenovirus 35 or said functional equivalent, said functional equivalent being an adenovirus, which encounters pre-existing immunity in less than about 10% of the hosts to which it is administered for the first time.
Patent NZ-521567-A (NZ)
Title: Vascostatin and other nidogen domains for use in arresting cell proliferation in vivo
Inventor: KALLURI RAGHURAM
IPC: A61K35/76
Filed: 2001-03-28
Abstract: Described are proteins comprising the C-terminal globular domain of nidogen having anti-angiogenic properties. Particularly described is a protein designated "Vascostatin," and to biologically active (e. g., anti-angiogenic) fragments, mutants, analogues, homologues and derivatives thereof, as well as multimers (e.g., dimers, trimers, etc.) and chimeric or fusion proteins thereof. In particular, Vascostatin is a monomeric protein, and arrests endothelial cell proliferation in vivo.
Patent NZ-523669-A (NZ)
Title: Biodegradable polymeric cellulose composition and products prepared therefrom
Inventor: LECKEY RICHARD ANTHONY
IPC: B27N3/04
Filed: 2001-07-13
Abstract: A composition for forming a wood substitute is disclosed, which comprises 30 to 70% (volume by volume) of a high molecular weight aliphatic polyester and comminuted cellulose-containing plant material, wherein the aliphatic polyester comprises 1,4- butanediol condensed with adipic acid and/or succinic acid, also disclosed is a process for the production of wood substitute from the composition and that has characteristics of natural wood. Articles made from this wood substitute are biodegradable and do not give off toxic fumes when combusted.
Patent NZ-525417-A (NZ)
Title: Substituted 5-amino-1-pentene-3-ol derivatives
Inventor: BUSCHMANN HELMUT
IPC: A61P25/28
Filed: 2001-09-28
Abstract: A substituted 5-amino-1-penten-3-ol derivative of the general formula I, is disclosed. Processes for the preparation of these compounds are also described. Medicaments comprising these compounds are useful in the treatment of pain, epilepsy, hot flushes, post-menopausal discomfort, amyotropic lateral sclerosis, reflex sympathetic dystrophy, spastic palsy, restless leg syndrome, acquired nystagmus; psychiatric or neuropathological disorders; painful diabetic neuropathy, symptoms and pain caused by multiple sclerosis or Parkinson's disease, neurodegenerative diseases; gastrointestinal damage; erythromelalgic or post-poliomyelitic pain, trigeminal or post-herpes neuralgia; or as an anticonvulsive, analgesic or anxiolytic.
Patent NZ-527232-A (NZ)
Title: A composition contaning a PDE 4 inhibitor and a beta adrenergic bronchodilator useful for treating pulmonary diseases
Inventor: NIEMAN RICHARD
IPC: A61K31/275
Filed: 1999-08-24
Abstract: A composition for treating a pulmonary disease comprising an effective amount of a PDE4 inhibitor such as cis-[4- cyano-4-(3-cyclopentyloxy-4-methoxyphenyl)cyclohexan-1-carboxylate]; an effective amount of a long-acting beta adrenergic bronchodilator such as formoterol; and a pharmaceutically acceptable excipient is disclosed. (62) Divided Out of 509777
Patent NZ-528054-A (NZ)
Title: Pipeline isolating device with guide rods between plunger and boot
Inventor: BURLOCK RICHARD
IPC: F16L55/10
Filed: 2002-03-13
Abstract: A pipeline isolating device is disclosed for installation into and occlusion of a pressurised liquid or fluid supply pipe comprising a substantially solid and deformable boot (1) which is adapted to move between an expanded and an unexpanded state and a shaped plunger (2) adapted to move into and out of said boot (1) wherein the boot (1) has a hollow interior (3) with a displacement contour (6) adapted to receive and cooperate with said plunger (2) so as to cause said boot (1) to move between said expanded state when the plunger (2) is inserted into said hollow interior (3) of the boot (1) and said unexpanded state when said plunger (2) is withdrawn from the interior (3) of the boot (1). One or more guide rods 16 is provided so as to guide the plunger axially in and out of the boot and minimise any deflection of the boot under pressure.
Patent NZ-540275-A (NZ)
Title: Calcilytic compounds and their use as calcium receptor antagonists
Inventor: MARQUIS ROBERT W
IPC: C07C217/36
Filed: 2003-11-25
Abstract: Calcilytic compounds of formula (I), pharmaceutically acceptable salts and complexes thereof are disclosed, wherein: R1 and R5 are independently selected from the group consisting of H and halogen; R2 and R3 are independently selected from the group consisting of H, halogen and J-K wherein: J is a covalent bond, alkylene or alkenyl: and K is selected from the group of CO2R8, such that R8 is H or alkyl; R4 is J1-K1 wherein: J1 represents C2-C4 alkylene or C2-C4 alkenyl, and K1 represents CO2H, CO2Me or CO2Et; R6 is selected from the group consisting of H or alkyl; R7 is indanyl, unsubstituted or substituted with any substituent selected from the group consisting of OH, halogen, C1-4 alkyl, C1-4 alkoxy, C3-6 cycloalkyl CF3, OCF3, CN and NO2. These calcilytic compounds are suitable for increasing serum parathyroid hormone levels in mammals; and for treating disease or disorder characterized by abnormal bone or mineral homeostasis, wherein the bone or mineral disorder is selected from the group consisting of osteosarcoma, periodontal disease, fracture healing, osteoathritis, rheumatoid arthritis, Paget's decease, humoral hypercalcemia malignancy, and osteoporosis.
Patent NZ-544117-A (NZ)
Title: Polyester composition for hot fill applications, containers made therewith, and methods
Inventor: SHI YU
IPC: C08G63/183
Filed: 2004-06-10
Abstract: A process for hot filling a heat-set container is disclosed. The process comprises the steps of heating a perform which comprises a PET copolymer to a temperature from above the glass transition temperature of the PET copolymer to about 140 degrees Celsius, wherein the PET copolymer consists essentially of a diacid component having repeat units from 95 to 99.75 mole percent terephthalic acid and from 5 to 0.25 mole percent naphthalenedicarboxylic acid and a diol component having repeat units from greater than 98.4 mole percent ethylene glycol and less than 1.6 percent diethylene glycol, based on 100 mole percent dacid component and 100 mole percent diol component. The preform is then positioned in a mold which is heated to a temperature from about 60 degrees Celsius to about 200 degrees Celsius. The heated preform is then stretched and expanded into the heated mold to form a container, which is then cooled. The container is then filled with a liquid heated above 85 degrees Celsius.
Patent NZ-544821-A (NZ)
Title: Binding molecules against SARS-Coronavirus and uses thereof
Inventor: TER MEULEN JAN HENRIK
IPC: A61K39/215
Filed: 2004-07-21
Abstract: Provided is a human binding molecule capable of specifically binding to a SARS-CoV and having SARS-CoV neutralizing activity, including molecules which comprise a specified CDR3 sequence. Further provided are corresponding pharmaceuticals, nucleic acids, vectors and methods of producing a medicament for diagnosing and treating a condition resulting from SARS-CoV
Patent NZ-547129-A (NZ)
Title: Methods of using and compositions comprising immunomodulatory compounds such as 1-oxo-2-(2,6-dioxopiperidin-3-yl)4-methylisoindoline for treatment, modification and management of pain
Inventor: ZELDIS JEROME B
IPC: A61K31/454
Filed: 2004-04-23
Abstract: Compounds of formulae (I) and (II), wherein the Y is oxygen or H2, a first of R1 and R2 is halo, alkyl, alkoxy, alkylamino, dialkylamino, cyano, or carbamoyl, the second of R1 and R2, independently of the first, is hydrogen, halo, alkyl, alkoxy, alkylamino, dialkylamino, cyano, or carbamoyl, and R3 is hydrogen, alkyl, or benzyl; can be used to treat pain.
Patent NZ-548151-A (NZ)
Title: Absorbent structure and absorbent article comprising the absorbent structure
Inventor: OSTERDAHL EJE
IPC: A61F/
Filed: 2004-12-16
Abstract: An absorbent structure (103) for use in a diaper (100), an incontinence pad, a sanitary towel is disclosed. The absorbent structure has at least one absorbent layer (112) comprising fluff pulp and superabsorbent particles. The average absorption capacity per superabsorbent particle in the absorbent layer is greater than 8.0 mg sodium chloride solution, and the number of superabsorbent particles per cm3 of the absorbent layer is smaller than 1100.
Patent NZ-548947-A (NZ)
Title: Pouch for collecting human body waste and drainage adapter therefor
Inventor: BUGLINO DONALD E
Filed: 2006-08-04
Abstract: A drainable pouch (10) for collecting human body waste is disclosed. The pouch includes first (12) and second walls that define a collection region, and a discharge portion (30) that can be folded into a sealed closed position. The pouch also includes a flap (40) that can be folded to embrace the discharge portion when it is in the sealed closed position. The flap is permanently sealed to the first and second walls by a seal (38) extending through at least one of the first and second walls to the other.
Patent NZ-549142-A (NZ)
Title: Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinases
Inventor: CHARRIER JEAN-DAMIEN
IPC: C07D403/14
Filed: 2003-06-19
Abstract: Disclosed is a compound of formula V or a salt, tautomer, or stereoisomer of a salt thereof, wherein R5 is selected from hydrogen or C1 -4 aliphatic; R6 is selected from C1 -3 aliphatic; and R7 is selected from C1 -4 aliphatic; provided that when R5 and R6 are methyl, R7 is neither cyclopropyl nor ethyl. The compounds are Aurora kinase inhibitors useful for treating cancer.